Candidiasis: Predisposing Factors, Prevention, Diagnosis and Alternative Treatment

  title={Candidiasis: Predisposing Factors, Prevention, Diagnosis and Alternative Treatment},
  author={Nat{\'a}lia Martins and Isabel C.F.R. Ferreira and Lillian Barros and S{\'o}nia Silva and Mariana Henriques},
Candidiasis is the most common opportunistic yeast infection. Candida species and other microorganisms are involved in this complicated fungal infection, but Candida albicans continues to be the most prevalent. In the past two decades, it has been observed an abnormal overgrowth in the gastrointestinal, urinary and respiratory tracts, not only in immunocompromised patients, but also related to nosocomial infections and even in healthy individuals. There is a widely variety of causal factors… 

Diagnosis and treatment of mucosa Candida spp . infections – a review

Results of many studies indicate that there is no need to implement treatment in sexual partners of patients suffering from VVC / rVVC, and more effective oral terbinaine or itraconazole is used instead of oral griseofulvin.

Clinical Appearance of Oral Candida Infection and Therapeutic Strategies

The treatment after confirmation of the diagnosis of oral candida infections should include recognizing and eliminating the underlying causes such as ill-fitting oral appliances, history of medications, immunological and endocrine disorders, nutritional deficiency states and prolonged hospitalization.

Clinical Manifestations of Candidiasis: Beyond Candida albicans

  • M. C. Hanna
  • Biology, Medicine
    Virology & Immunology Journal
  • 2019
Treatment of candidiasis rely on three principal antifungal agents; azoles, polyenes, and echinocandins; these three drug classes have specific drug target.

Predisposing factors endorsing Candida infections.

  • Shweta SinghZ. FatimaS. Hameed
  • Medicine, Biology
    Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive
  • 2015
The need to understand the various predisposing factors leading to Candidal infections is established and the various factors discussed on a common platform are discussed.

Clinical and pathogenicity aspects of Candida species

Candida species normally exist as commensals of the skin and mucosa, but they are also opportunistic pathogens, with the ability to cause a variety of superficial and invasive diseases. Among the

Infection control measures to prevent hospital transmission of candida

Infection control measures to prevent hospital transmission of candida are very important and compliance with hand hygiene before and after contact with the patient is the most important step to prevent the spreading of Candida spp.

Oral Cavity and Candida albicans: Colonisation to the Development of Infection

Conventional oral hygiene products containing antimicrobial compounds, essential oils and phytochemicals can be considered, these products can maintain the low number of Candida in the oral cavity and reduce their virulence.

The Interplay Between Sugar and Yeast Infections: Do Diabetics Have a Greater Predisposition to Develop Oral and Vulvovaginal Candidiasis?

The results of the review show that DM patients have an increased susceptibility to Candida sp.

Espèce Candida : l ' ennemi silencieux

This review is an attempt to provide up-to-date information on the persistent problems of Candida with highlights on the clinical importance, molecular diagnosis, and resistance to candidate antifungal drugs; azoles and echinocandins.

Candidiasis-Oral Manifestations: A Literature Review

A literature systemic review of the different predisposing factors, clinical oral manifestations and diagnosis of oral candidiasis in dental practice is provided, based on a literature review of latest updates of various different researches.



The epidemiology of hematogenous candidiasis caused by different Candida species.

There has been a substantial shift in the epidemiology of hematogenous candidiasis caused by different Candida species in recent years, and fluconazole appears to be playing a major role in this observed shift.

Oropharyngeal candidiasis: a review of its clinical spectrum and current therapies.

Epidemiology of Candida species infections in critically ill non-immunosuppressed patients.

Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome.

Virulence factors of Candida albicans.

Mixed oropharyngeal candidiasis due toCandida albicans and non-albicans Candida strains in HIV-infected patients

It is concluded that non-albicans strains ofCandida, less sensitive to azole drugs than theirCandida albicans counterparts, are not clinically relevant in episodes of mixed oropharyngeal candidiasis in HIV-1-infected patients.

Distribution of Candida species among HIV-positive patients with oropharyngeal candidiasis in Accra, Ghana.

A baseline Candida species identification was undertaken in 267 HIV-infected patients with oropharyngeal candidiasis for future reference to identifyCandida species causing severe infections.